Sai Parenteral’s IPO Description – Sai Parenteral’s is a diversified pharmaceutical formulations player with integrated capabilities across research, development, and manufacturing, operating through two core verticals: Branded Generic Formulations and Contract Development and Manufacturing Organisation …

Jagsonpal Pharmaceuticals Buyback Record Date is not finalized.  Jagsonpal Pharmaceuticals is a pharmaceutical company engaged in the manufacturing and marketing of branded generic formulations across multiple therapeutic segments. Jagsonpal primarily focuses on the domestic formulations …

If you’ve been tracking IPO market, this news is critically important for you. On 13 March 2026, the government of India officially updated the rules for Initial Public Offerings (IPOs) to make it easier for …

The Securities and Exchange Board of India (SEBI) gave observation letters to three companies during the second week of March 2026. Conversely, two companies had their offer documents either withdrawn or returned by the regulator. …

Narmada Macplast Rights Issue dates is not finalized. Narmada Macplast Drip Irrigation Systems is a micro-irrigation solutions provider focused on water management products for the agriculture sector. The company operates in the manufacturing and supply …

GSP Crop Science IPO GMP Today (Daily Trend) Currently, activity in the grey market is in an early stage; however, as the subscription date draws closer, we may witness increased activity in the premiums. GSP …